A single-use, self-administered microneedle technology to provide immunization against infectious diseases has recently been validated by preclinical research trials. A single-use, self-administered ...

Significant advances in the outcome of patients with malignant blood diseases took place over the past decades. Although adopting further breakthroughs in medical sciences, clinicians also continue to ...

BIMZELX ® (bimekizumab-bkzx) is now commercially available by prescription in the United States in a 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX The single-injection ...

This program was developed to prepare pharmacists to administer medications and immunizations by injection. The legislation surrounding this expanded scope of practice is in various stages in each ...

Immune responses against oncolytic adenovirus (Ad) vectors are thought to limit vector anti-tumor efficacy. With Syrian hamsters, which are immunocompetent and whose tumors and normal tissues are ...

(RTTNews) - UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available. These are in addition to the 1 mL device administration ...

Credit: UCB The new presentations allow for single administration for certain indications. The new presentations allow for single administration to treat plaque psoriasis, hidradenitis suppurativa, ...

BIMZELX® (bimekizumab-bkzx) is now commercially available by prescription in the United States in a 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX The single-injection ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...